Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Gillies Hunter. Insider active across 1 company, notably Aerovate Therapeutics, Inc.. In total, 17 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €72k. History available since 21 April 2023. The latest transaction was filed on 13 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
6,000 shares@ US$2.147.0% of flowCommon StockSEC:0001415889-24-016993:0
4,000 shares@ US$2.144.6% of flowCommon StockSEC:0001415889-24-013630:0
4,000 shares@ US$1.743.8% of flowCommon StockSEC:0001415889-24-011251:0
9,000 shares@ US$2.1410.4% of flowCommon StockSEC:0001415889-24-009596:0
4,000 shares@ US$1.743.7% of flowCommon StockSEC:0001415889-24-008771:0
8,975 shares@ US$2.1410.3% of flowCommon StockSEC:0001415889-24-007533:0
511 shares@ US$1.740.5% of flowCommon StockSEC:0001415889-24-005571:0
3,489 shares@ US$1.743.3% of flowCommon StockSEC:0001415889-24-004903:0
4,000 shares@ US$1.743.7% of flowCommon StockSEC:0001415889-24-001609:0
125 shares@ US$2.140.1% of flowCommon StockSEC:0001415889-23-017025:0
4,000 shares@ US$1.743.8% of flowCommon StockSEC:0001415889-23-016908:0
2,103 shares@ US$1.742.0% of flowCommon StockSEC:0001415889-23-016539:0
65 shares@ US$1.740.1% of flowCommon StockSEC:0001415889-23-008658:0
65 shares@ US$19.500.7% of flowCommon StockSEC:0001415889-23-008658:1
1,090 shares@ US$1.741.0% of flowCommon StockSEC:0001415889-23-008425:0
4,000 shares@ US$1.743.7% of flowCommon StockSEC:0001415889-23-006838:0
4,000 shares@ US$19.5041.4% of flowCommon StockSEC:0001415889-23-006838:1